The most direct answer is no one knows for certain.
I don't think it's a matter of if they'll release results for both safety and efficacy or if the results aren't positive. It's just a matter of time when and how they decide to communicate the results. Mgmt may decide to release the info with the upcoming 10K this week (or if they request an extension no later than 4/15) or they may decide to publish the results in a technical journal for peer review sometime soon.
Exact timing is unknown but I believe results will be shared sooner than later. If released this week then great, but if not it's not a red flag. Recent news indicated results are positive so let's give management some time to prepare the technical details for release and share them how they think is best.
To answer your question my understanding is that we should be waiting for both but the most important of the two is its safety as far as the IRB is concerned. The study should be completed by the end of march but that doesn't mean they will immediately get the "regulatory approvals".
View it this way: By the end of March OWCP should have completed its exam. They will then be handing it in and they will have to wait for the professor to mark the exam and give the pass that they will need to get into production.
What we don't need is a press release saying "we finished the exam". What we want to hear is: Mom Dad, guess what? I passed and got an "A". If this is the scenario then there is nothing wrong with waiting until possibly sometime in April.
"Perfect clarity"? Hmm... If you're looking for perfection, you're looking in the wrong places. No perfection in this and the rest of the whole process of running the business or trading/investing in the stock market. Just the reality. GLTY
News 
Market Data 
Discover 
